Posted by Michael Wonder on 27 Mar 2019
Cancer advocate: PHARMAC is 'compromised' by limited spending
27 March 2019 - Malcolm Mulholland says he has been told that oncologists advising PHARMAC feel uncomfortable with their practices.
The backlash against PHARMAC continues, with claims that oncologists advising the agency feel "compromised" by limited funding.
Breast cancer patients are amongst those calling for a review of the drug purchasing agency over concerns about their priorities.
Amongst those unhappy with her response is cancer advocate Malcolm Mulholland, who was one of the first to call for an inquiry.
